查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
再生醫學市場 - 按類型（細胞治療、組織工程、基因治療）、按應用（腫瘤學、皮膚病學、肌肉骨骼、神經病學、心血管、傷口癒合、眼科）、全球預測（2023-2032）
市場調查報告書
商品編碼
1373359

再生醫學市場 - 按類型（細胞治療、組織工程、基因治療）、按應用（腫瘤學、皮膚病學、肌肉骨骼、神經病學、心血管、傷口癒合、眼科）、全球預測（2023-2032）

Regenerative Medicine Market - By Type (Cell Therapy, Tissue Engineering, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology), Global Forecast (2023-2032)
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

2023年至2032年，再生醫學市場規模將以20.4%的年複合成長率成長。全球人口老化正在增加慢性病的盛行率，對再生療法產生了很高的需求。幹細胞研究、基因治療和組織工程的不斷進步也擴大了治療選擇的可用性，使再生醫學在全球範圍內更加可行和有效。例如，2022年1月，諾華與Alnylam建立了策略夥伴關係，利用後者專有的siRNA技術來創造一種刺激功能性肝細胞再生的新療法。

加速再生醫學研發活動的投資和資金增加可歸因於監管支持的激增和核准流程的簡化。個人化醫療的潛力不斷成長，以及為了吸引患者和醫療保健提供者而更加重視治療以前無法治癒的疾病，也將有助於產業的擴張。

再生醫學行業根據類型、應用和地區進行分類。

根據類型，在基因工程技術的進步和基因治療研究資金激增的推動下，預計從 2032 年到 2032 年，基因治療領域的行業價值將以年複合成長率大幅成長。基因療法治療以前無法治療的遺傳性疾病的潛力也將推動該細分市場的成長。

預計神經學應用領域在預測期內將在再生醫學市場中佔據相當大的收入佔有率。阿茲海默症和帕金森氏症等神經系統疾病的盛行率不斷上升，正在為基於幹細胞的創新療法的開發讓路。此外，人口老化的加劇和研究經費的增加將推動該領域的成長。

從地區來看，亞太地區再生醫學產業將在 2023 年至 2032 年期間以強勁的年複合成長率擴張。這一成長可歸因於該地區人口老化的加劇和醫療基礎設施的增加。研發投資的增加以及有利的政府措施的推出也將有助於該地區再生療法的需求不斷成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：再生醫學市場洞察

  • 產業格局
  • 產業影響力
    • 成長動力
      • 全球慢性病盛行率不斷上升
      • 創新藥物開發投資不斷增加
      • 幹細胞技術在疾病治療的高度採用
      • 強大的潛在療法產品線
    • 產業陷阱與挑戰
      • 嚴格的監管框架
      • 與某些再生醫學治療相關的高成本
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 全球公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀錶板

第 5 章：再生醫學市場估計與預測：按類型，2018-2032

  • 主要動向：依類型
  • 細胞療法
  • 組織工程
  • 基因治療
  • 其他類型

第 6 章：再生醫學市場估計與預測：按應用，2018-2032

  • 主要動向：按應用
  • 腫瘤學
  • 肌肉骨骼
  • 神經病學
  • 心血管
  • 傷口癒合
  • 眼科
  • 其他應用

第 7 章：再生醫學市場估計與預測：按地區，2018-2032

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 瑞典
    • 荷蘭人
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 8 章：公司簡介

  • Novartis AG
  • Amgen Inc.
  • Bristol Myers Squibb
  • BLUEBIRD BIO
  • GC Pharma
  • GlaxoSmithKline plc
  • ANTEROGEN
  • BIOSOLUTIONS
  • TERUMO BCT
  • AVITA MEDICAL
  • Smith and Nephew
  • ORGANOGENESIS
Product Code: 4571

Regenerative medicine market size will grow at 20.4% CAGR from 2023 to 2032. The aging global population is increasing the prevalence of chronic diseases, creating high demand for regenerative therapies. The rising advancements in stem cell research, gene therapy, and tissue engineering are also expanding the availability of treatment options for making regenerative medicine more viable and effective worldwide. For instance, in January 2022, Novartis initiated a strategic partnership with Alnylam to harness the latter's proprietary siRNA technology in a bid to create a new therapy for stimulating the regeneration of functional liver cells.

Increasing investments and funding for expediting research and development activities in regenerative medicine can be attributed to the surging regulatory support and streamlined approval processes. The rising potential for personalized medicine and the higher focus on treating previously incurable conditions for attracting both patients and healthcare providers will also contribute to the industry expansion.

The regenerative medicine industry is categorized based on type, application, and region.

Based on type, the industry value from the gene therapy segment is projected to increase at substantial CAGR from 2032 to 2032, driven by advancements in genetic engineering techniques and the surging funding for gene therapy research. The potential of gene therapy to treat previously untreatable genetic disorders will also push the segment growth.

The neurology application segment is anticipated to account for sizeable revenue share of the regenerative medicine market during the forecast period. The rising prevalence of neurological disorders, such as Alzheimer's and Parkinson's disease is making way for the development of innovative stem cell-based therapies. In addition, the growing aging population and increasing research funding will drive the segment growth.

Regionally, the Asia Pacific regenerative medicine industry will expand at a robust CAGR during 2023-2032. The growth can be attributed to the growing aging population and increasing healthcare infrastructure in the region. The rising investments in research and development and the rollout of favorable government initiatives will also contribute to the burgeoning demand for regenerative therapies in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Secondary
      • 1.6.1.1 Paid sources
      • 1.6.1.2 Public sources
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Regenerative medicine industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Region trends
    • 2.1.3 Type trends
    • 2.1.4 Application trends

Chapter 3 Regenerative Medicine Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of chronic diseases worldwide
      • 3.2.1.2 Rising investment in development of innovative medicines
      • 3.2.1.3 High adoption of stem cell technology in disease treatment
      • 3.2.1.4 Strong product pipeline of potential therapies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory framework
      • 3.2.2.2 High cost associated with some regenerative medicine therapy
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By application
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Global company market share analysis, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Regenerative Medicine Market Estimates and Forecast, By Type, 2018-2032 (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Cell therapy
  • 5.3 Tissue engineering
  • 5.4 Gene therapy
  • 5.5 Other types

Chapter 6 Regenerative Medicine Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

  • 6.1 Key trends, by application
  • 6.2 Oncology
  • 6.3 Musculoskeletal
  • 6.4 Neurology
  • 6.5 Cardiovascular
  • 6.6 Wound healing
  • 6.7 Ophthalmology
  • 6.8 Other applications

Chapter 7 Regenerative Medicine Market Estimates and Forecast, By Region, 2018-2032 (USD Million)

  • 7.1 Key trends, by region
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Sweden
    • 7.3.7 The Netherlands
    • 7.3.8 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East & Africa

Chapter 8 Company Profiles

  • 8.1 Novartis AG
  • 8.2 Amgen Inc.
  • 8.3 Bristol Myers Squibb
  • 8.4 BLUEBIRD BIO
  • 8.5 GC Pharma
  • 8.6 GlaxoSmithKline plc
  • 8.7 ANTEROGEN
  • 8.8 BIOSOLUTIONS
  • 8.9 TERUMO BCT
  • 8.10 AVITA MEDICAL
  • 8.11 Smith and Nephew
  • 8.12 ORGANOGENESIS

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by type (2022)
  • TABLE 3 Market revenue, by application (2022)
  • TABLE 4 Market share, by region (2022)
  • TABLE 5 Global regenerative medicine market size, by region, 2018 - 2022 (USD Million)
  • TABLE 6 Global regenerative medicine market size, by region, 2023 - 2032 (USD Million)
  • TABLE 7 Global regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 8 Global regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 9 Global regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 10 Global regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 Competitive benchmarking of major market players
  • TABLE 13 Competitive positioning matrix: Classification criteria
  • TABLE 14 Strategic outlook matrix: Classification criteria
  • TABLE 15 Cell therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 16 Cell therapy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 17 Tissue engineering market size, by region, 2018 - 2022 (USD Million)
  • TABLE 18 Tissue engineering market size, by region, 2023 - 2032 (USD Million)
  • TABLE 19 Gene therapy market size, by region, 2018 - 2022 (USD Million)
  • TABLE 20 Gene therapy market size, by region, 2023 - 2032 (USD Million)
  • TABLE 21 Other types market size, by region, 2018 - 2022 (USD Million)
  • TABLE 22 Other types market size, by region, 2023 - 2032 (USD Million)
  • TABLE 23 Oncology market size, by region, 2018 - 2022 (USD Million)
  • TABLE 24 Oncology market size, by region, 2023 - 2032 (USD Million)
  • TABLE 25 Musculoskeletal market size, by region, 2018 - 2022 (USD Million)
  • TABLE 26 Musculoskeletal market size, by region, 2023 - 2032 (USD Million)
  • TABLE 27 Neurology market size, by region, 2018 - 2022 (USD Million)
  • TABLE 28 Neurology market size, by region, 2023 - 2032 (USD Million)
  • TABLE 29 Cardiovascular market size, by region, 2018 - 2022 (USD Million)
  • TABLE 30 Cardiovascular market size, by region, 2023 - 2032 (USD Million)
  • TABLE 31 Wound healing market size, by region, 2018 - 2022 (USD Million)
  • TABLE 32 Wound healing market size, by region, 2023 - 2032 (USD Million)
  • TABLE 33 Ophthalmology market size, by region, 2018 - 2022 (USD Million)
  • TABLE 34 Ophthalmology market size, by region, 2023 - 2032 (USD Million)
  • TABLE 35 Other applications market size, by region, 2018 - 2022 (USD Million)
  • TABLE 36 Other applications market size, by region, 2023 - 2032 (USD Million)
  • TABLE 37 North America regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 38 North America regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 39 North America regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 40 North America regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 41 North America regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 42 North America regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 43 U.S. regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 44 U.S. regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 45 U.S. regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 46 U.S. regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 47 Canada regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 48 Canada regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 49 Canada regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 50 Canada regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 51 Europe regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 52 Europe regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 53 Europe regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 54 Europe regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 55 Europe regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 56 Europe regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 57 Germany regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 58 Germany regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 59 Germany regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 60 Germany regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 61 UK regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 62 UK regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 63 UK regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 64 UK regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 65 France regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 66 France regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 67 France regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 68 France regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 69 Spain regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 70 Spain regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 71 Spain regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 72 Spain regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 73 Italy regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 74 Italy regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 75 Italy regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 76 Italy regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 77 Sweden regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 78 Sweden regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 79 Sweden regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 80 Sweden regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 81 The Netherlands regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 82 The Netherlands regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 83 The Netherlands regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 84 The Netherlands regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 85 Rest of Europe regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 86 Rest of Europe regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 87 Rest of Europe regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 88 Rest of Europe regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 89 Asia Pacific regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 90 Asia Pacific regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 91 Asia Pacific regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 92 Asia Pacific regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 93 Asia Pacific regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 94 Asia Pacific regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 95 China regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 96 China regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 97 China regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 98 China regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 99 Japan regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 100 Japan regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 101 Japan regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 102 Japan regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 103 India regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 104 India regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 105 India regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 106 India regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 107 Australia regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 108 Australia regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 109 Australia regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 110 Australia regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 111 South Korea regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 112 South Korea regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 113 South Korea regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 114 South Korea regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 115 Rest of Asia Pacific regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 116 Rest of Asia Pacific regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 117 Rest of Asia Pacific regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 118 Rest of Asia Pacific regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 119 Latin America regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 120 Latin America regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 121 Latin America regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 122 Latin America regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 123 Latin America regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 124 Latin America regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 125 Brazil regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 126 Brazil regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 127 Brazil regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 128 Brazil regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 129 Mexico regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 130 Mexico regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 131 Mexico regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 132 Mexico regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 133 Argentina regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 134 Argentina regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 135 Argentina regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 136 Argentina regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 137 Rest of Latin America regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 138 Rest of Latin America regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 139 Rest of Latin America regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 140 Rest of Latin America regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 141 Middle East & Africa regenerative medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 142 Middle East & Africa regenerative medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 143 Middle East & Africa regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 144 Middle East & Africa regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 145 Middle East & Africa regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 146 Middle East & Africa regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 147 South Africa regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 148 South Africa regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 149 South Africa regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 150 South Africa regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 151 Saudi Arabia regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 152 Saudi Arabia regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 153 Saudi Arabia regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 154 Saudi Arabia regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 155 UAE regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 156 UAE regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 157 UAE regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 158 UAE regenerative medicine market size, by application, 2023 - 2032 (USD Million)
  • TABLE 159 Rest of Middle East & Africa regenerative medicine market size, by type, 2018 - 2022 (USD Million)
  • TABLE 160 Rest of Middle East & Africa regenerative medicine market size, by type, 2023 - 2032 (USD Million)
  • TABLE 161 Rest of Middle East & Africa regenerative medicine market size, by application, 2018 - 2022 (USD Million)
  • TABLE 162 Rest of Middle East & Africa regenerative medicine market size, by application, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Regenerative medicine industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by application
  • FIG 9 Porter's analysis
  • FIG 10 PESTEL analysis
  • FIG 11 Company matrix analysis, 2022
  • FIG 12 Global company market share analysis, 2022
  • FIG 13 Competitive positioning matrix, 2022
  • FIG 14 Strategic dashboard, 2022